|
2008-11-21 |
2008-11-19 |
B
Purchase
|
Zakrzewski Joseph S
Non-Executive Director
|
86,984
-9.6%
276.44
US$3,685,174
|
86,984
-9.6%
|
276.44
|
US$3,685,174
|
|
|
2008-10-08 |
2008-09-30 |
B
Purchase
|
Zakrzewski Joseph S
Non-Executive Director
|
8,815
+33.1%
263.81
US$3,687,111
|
8,815
+33.1%
|
263.81
|
US$3,687,111
|
|
|
2008-09-15 |
2008-09-15 |
B
Purchase
|
Zakrzewski Joseph S
Non-Executive Director
|
64,666
-9.2%
301.92
US$3,962,956
|
64,666
-9.2%
|
301.92
|
US$3,962,956
|
|
|
2008-09-15 |
2008-09-12 |
B
Purchase
|
Zakrzewski Joseph S
Non-Executive Director
|
10,000
+1.7%
0.04
US$370
|
10,000
+1.7%
|
0.04
|
US$370
|
|
|
2008-09-09 |
2008-09-09 |
B
Purchase
|
Zakrzewski Joseph S
Non-Executive Director
|
1,330
+0.2%
0.04
US$49
|
1,330
+0.2%
|
0.04
|
US$49
|
|
|
2008-09-09 |
2008-09-08 |
B
Purchase
|
Zakrzewski Joseph S
Non-Executive Director
|
51,500
+9.7%
0.04
US$1,906
|
51,500
+9.7%
|
0.04
|
US$1,906
|
|
|
2008-09-09 |
2008-09-05 |
B
Purchase
|
Zakrzewski Joseph S
Non-Executive Director
|
7,051
+1.3%
0.04
US$261
|
7,051
+1.3%
|
0.04
|
US$261
|
|
|
2008-09-02 |
2008-08-27 |
B
Purchase
|
Zakrzewski Joseph S
Non-Executive Director
|
200,000
+61.5%
0.04
US$7,000
|
200,000
+61.5%
|
0.04
|
US$7,000
|
|
|
2008-07-18 |
2008-07-16 |
B
Purchase
|
Zakrzewski Joseph S
Non-Executive Director
|
10,495
+4.9%
0.04
US$378
|
10,495
+4.9%
|
0.04
|
US$378
|
|
|
2008-07-01 |
2008-06-30 |
B
Purchase
|
Zakrzewski Joseph S
Non-Executive Director
|
75,826
+54.6%
0.04
US$2,730
|
75,826
+54.6%
|
0.04
|
US$2,730
|
|
|
2008-07-01 |
2008-06-27 |
B
Purchase
|
Zakrzewski Joseph S
Non-Executive Director
|
1,000
+0.7%
0.04
US$36
|
1,000
+0.7%
|
0.04
|
US$36
|
|
|
2008-04-08 |
2008-04-03 |
B
Purchase
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
100,000
+263.2%
0.05
US$5,300
|
100,000
+263.2%
|
0.05
|
US$5,300
|
|
|
2008-01-17 |
2008-01-09 |
B
Purchase
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
13,800
+55.4%
0.07
US$966
|
13,800
+55.4%
|
0.07
|
US$966
|
|
|
2007-09-10 |
2007-09-07 |
B
Purchase
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
25,000
+inf%
0.20
US$5,000
|
25,000
+inf%
|
0.20
|
US$5,000
|
|
|
2006-07-10 |
2006-07-07 |
B
Purchase
|
Ashe Patrick
Non-Executive Director
|
45,000
+inf%
2.32
US$104,400
|
45,000
+inf%
|
2.32
|
US$104,400
|
|
|
2006-05-26 |
2006-05-25 |
B
Purchase
|
Myers Scott Dunseth
Senior Vice President
Officer
|
5,000
+100.0%
2.69
US$13,450
|
5,000
+100.0%
|
2.69
|
US$13,450
|
|
|
2006-05-26 |
2006-05-24 |
B
Purchase
|
Myers Scott Dunseth
Senior Vice President
Officer
|
5,000
+inf%
2.69
US$13,450
|
5,000
+inf%
|
2.69
|
US$13,450
|
|
|
2006-05-18 |
2006-05-16 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
258,858
-50.1%
3.25
US$841,288
|
258,858
-50.1%
|
3.25
|
US$841,288
|
|
|
2006-05-18 |
2006-05-16 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
11,422
-50.0%
3.25
US$37,122
|
11,422
-50.0%
|
3.25
|
US$37,122
|
|
|
2006-05-18 |
2006-05-16 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
547,491
-50.0%
3.25
US$1,779,346
|
547,491
-50.0%
|
3.25
|
US$1,779,346
|
|
|
2006-04-05 |
2006-04-03 |
PlS
Planned sale
|
Skolnick Phil
Sr. V.P. Research, CSO
Officer
|
5,000
-100.0%
16.05
US$80,260
|
5,000
-100.0%
|
16.05
|
US$80,260
|
|
|
2006-03-15 |
2006-03-13 |
PlS
Planned sale
|
HOROVITZ ZOLA P
Non-Executive Director
|
12,400
-19.8%
17.43
US$216,085
|
12,400
-19.8%
|
17.43
|
US$216,085
|
|
|
2006-03-02 |
2006-03-01 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CSO
Officer
|
2,000
-100.0%
19.42
US$38,840
|
2,000
-100.0%
|
19.42
|
US$38,840
|
|
|
2006-03-02 |
2006-03-01 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CSO
Officer
|
1,000
-33.3%
19.43
US$19,430
|
1,000
-33.3%
|
19.43
|
US$19,430
|
|
|
2006-03-02 |
2006-03-01 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CSO
Officer
|
2,000
-40.0%
19.40
US$38,800
|
2,000
-40.0%
|
19.40
|
US$38,800
|
|
|
2006-03-02 |
2006-03-01 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CSO
Officer
|
5,000
-50.0%
19.30
US$96,500
|
5,000
-50.0%
|
19.30
|
US$96,500
|
|
|
2006-02-13 |
2006-02-13 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
21,700
-46.5%
19.00
US$412,300
|
21,700
-46.5%
|
19.00
|
US$412,300
|
|
|
2006-02-13 |
2006-02-13 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
1,900
-3.9%
19.01
US$36,119
|
1,900
-3.9%
|
19.01
|
US$36,119
|
|
|
2006-02-13 |
2006-02-13 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
1,400
-2.8%
19.02
US$26,628
|
1,400
-2.8%
|
19.02
|
US$26,628
|
|
|
2006-02-13 |
2006-02-09 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
316,200
-41.9%
18.00
US$5,691,600
|
316,200
-41.9%
|
18.00
|
US$5,691,600
|
|
|
2006-02-13 |
2006-02-09 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
200
-0.0%
18.01
US$3,602
|
200
-0.0%
|
18.01
|
US$3,602
|
|
|
2006-02-13 |
2006-02-09 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CSO
Officer
|
30,000
-100.0%
18.05
US$541,500
|
30,000
-100.0%
|
18.05
|
US$541,500
|
|
|
2006-02-13 |
2006-02-09 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
20,000
-44.4%
18.00
US$360,000
|
20,000
-44.4%
|
18.00
|
US$360,000
|
|
|
2006-02-13 |
2006-02-09 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
300
-0.0%
18.10
US$5,430
|
300
-0.0%
|
18.10
|
US$5,430
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
1,600
-100.0%
17.00
US$27,200
|
1,600
-100.0%
|
17.00
|
US$27,200
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
100
-5.9%
17.01
US$1,701
|
100
-5.9%
|
17.01
|
US$1,701
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
400
-19.0%
17.02
US$6,808
|
400
-19.0%
|
17.02
|
US$6,808
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
100
-4.5%
17.03
US$1,703
|
100
-4.5%
|
17.03
|
US$1,703
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
2,300
-51.1%
17.05
US$39,215
|
2,300
-51.1%
|
17.05
|
US$39,215
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
2,200
-32.8%
17.10
US$37,620
|
2,200
-32.8%
|
17.10
|
US$37,620
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
1,000
-13.0%
17.11
US$17,110
|
1,000
-13.0%
|
17.11
|
US$17,110
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
2,300
-23.0%
17.12
US$39,376
|
2,300
-23.0%
|
17.12
|
US$39,376
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
600
-5.7%
17.13
US$10,278
|
600
-5.7%
|
17.13
|
US$10,278
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
1,400
-11.7%
17.14
US$23,996
|
1,400
-11.7%
|
17.14
|
US$23,996
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
1,000
-7.7%
17.15
US$17,150
|
1,000
-7.7%
|
17.15
|
US$17,150
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
1,600
-11.0%
17.16
US$27,456
|
1,600
-11.0%
|
17.16
|
US$27,456
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
200
-1.4%
17.17
US$3,434
|
200
-1.4%
|
17.17
|
US$3,434
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
100
-0.7%
17.18
US$1,718
|
100
-0.7%
|
17.18
|
US$1,718
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
1,500
-9.1%
17.19
US$25,785
|
1,500
-9.1%
|
17.19
|
US$25,785
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
2,600
-13.7%
17.20
US$44,720
|
2,600
-13.7%
|
17.20
|
US$44,720
|
|
|
2006-02-07 |
2006-02-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
SVP & CFO
Officer
|
1,000
-5.0%
17.21
US$17,210
|
1,000
-5.0%
|
17.21
|
US$17,210
|
|
|
2006-02-03 |
2006-02-01 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
S.V.P. & CSO
Officer
|
5,000
-100.0%
15.82
US$79,100
|
5,000
-100.0%
|
15.82
|
US$79,100
|
|
|
2006-01-12 |
2006-01-10 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
Sr. V.P. & C.S.O.
Officer
|
5,000
-100.0%
15.90
US$79,500
|
5,000
-100.0%
|
15.90
|
US$79,500
|
|
|
2006-01-12 |
2006-01-10 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
Sr. V.P. & C.S.O.
Officer
|
5,000
-50.0%
15.82
US$79,100
|
5,000
-50.0%
|
15.82
|
US$79,100
|
|
|
2005-11-09 |
2005-11-07 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
Sr. V.P. Research, CSO
Officer
|
5,000
-100.0%
15.82
US$79,100
|
5,000
-100.0%
|
15.82
|
US$79,100
|
|
|
2005-11-04 |
2005-11-04 |
S
Sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
83,300
-9.9%
15.27
US$1,271,991
|
83,300
-9.9%
|
15.27
|
US$1,271,991
|
|
|
2005-11-04 |
2005-11-03 |
S
Sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
79,500
-8.7%
15.07
US$1,197,970
|
79,500
-8.7%
|
15.07
|
US$1,197,970
|
|
|
2005-11-04 |
2005-11-02 |
S
Sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
37,200
-3.9%
15.27
US$567,951
|
37,200
-3.9%
|
15.27
|
US$567,951
|
|
|
2005-10-21 |
2005-10-17 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
10,500
-17.3%
14.52
US$152,500
|
10,500
-17.3%
|
14.52
|
US$152,500
|
|
|
2005-10-04 |
2005-10-03 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
Sr. V.P. Research, CSO
Officer
|
5,000
-100.0%
16.88
US$84,400
|
5,000
-100.0%
|
16.88
|
US$84,400
|
|
|
2005-09-09 |
2005-09-07 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
Sr. V.P. & CSO
Officer
|
5,000
-100.0%
15.82
US$79,100
|
5,000
-100.0%
|
15.82
|
US$79,100
|
|
|
2005-08-29 |
2005-08-25 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
33,300
-3.4%
18.00
US$599,400
|
33,300
-3.4%
|
18.00
|
US$599,400
|
|
|
2005-08-17 |
2005-08-15 |
PlS
Planned sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
15,000
-23.0%
18.17
US$272,510
|
15,000
-23.0%
|
18.17
|
US$272,510
|
|
|
2005-08-16 |
2005-08-15 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
138,400
-6.4%
18.24
US$2,524,416
|
138,400
-6.4%
|
18.24
|
US$2,524,416
|
|
|
2005-08-16 |
2005-08-12 |
S
Sale
|
ORBIMED ADVISORS LLC
Non-Executive Director
|
85,000
-3.8%
18.47
US$1,569,950
|
85,000
-3.8%
|
18.47
|
US$1,569,950
|
|
|
2005-06-28 |
2005-06-27 |
S
Sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
2,500
-4.7%
18.30
US$45,750
|
2,500
-4.7%
|
18.30
|
US$45,750
|
|
|
2005-06-28 |
2005-06-27 |
S
Sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
2,500
-4.5%
18.02
US$45,050
|
2,500
-4.5%
|
18.02
|
US$45,050
|
|
|
2005-06-28 |
2005-06-27 |
S
Sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
2,500
-4.3%
18.00
US$45,000
|
2,500
-4.3%
|
18.00
|
US$45,000
|
|
|
2005-06-28 |
2005-06-27 |
S
Sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
7,500
-11.5%
17.96
US$134,700
|
7,500
-11.5%
|
17.96
|
US$134,700
|
|
|
2005-05-17 |
2005-05-16 |
S
Sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
3,150
-100.0%
15.67
US$49,360
|
3,150
-100.0%
|
15.67
|
US$49,360
|
|
|
2005-05-17 |
2005-05-16 |
S
Sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
3,000
-48.8%
15.66
US$46,980
|
3,000
-48.8%
|
15.66
|
US$46,980
|
|
|
2005-05-17 |
2005-05-16 |
S
Sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
2,500
-28.9%
15.65
US$39,125
|
2,500
-28.9%
|
15.65
|
US$39,125
|
|
|
2005-05-17 |
2005-05-16 |
S
Sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
2,500
-22.4%
15.68
US$39,200
|
2,500
-22.4%
|
15.68
|
US$39,200
|
|
|
2005-05-17 |
2005-05-16 |
S
Sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
1,000
-8.2%
15.66
US$15,660
|
1,000
-8.2%
|
15.66
|
US$15,660
|
|
|
2004-11-12 |
2004-11-08 |
S
Sale
|
DOV PHARMACEUTICAL INC
Non-Executive Director
|
21,000
-29.5%
16.46
US$345,660
|
21,000
-29.5%
|
16.46
|
US$345,660
|
|